Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.
Content updated: 2026-11-22 22:41:59
- Yesterday's Close
- $198.06
- Today's Open
- $197.58
- Today's High
- $210.00
- Today's Low
- $191.50
- Volume
- 8.41M shares
- 52-Week Range
- $23.92-$280.80
As of 2026-11-22 22:41:59, Moderna (MRNA) was quoted at $199.30, a change of +$1.24 (+0.62%) from the previous close. The day's range was $191.50–$210.00, and the 52-week range was $23.92–$280.80.
Why Is Moderna (MRNA) Stock Rising?
AI Stock Price AnalysisContent updated: 2026-11-20 20:43:57
Shares climbed to an intraday high of $210 before fading to $195.33 at the snapshot, down 1.93% from the prior close and below the $201.95 volume-weighted average price (VWAP), a clear high-pullback structure. Discussion has centered on late-stage data for the personalized melanoma vaccine partnered with Merck and on cash spending as oncology investment rises.
About Moderna (MRNA)
- Ticker / Exchanges
- MRNA / NASDAQ
- Industry / Sector
- Biotechnology / Healthcare
- CEO
- Stéphane Bancel
- Headquarters
- Cambridge,MA,US
- Official Website
- https://www.modernatx.com
- Listing Date
- 2018-12-07
Recent Company Events
- 2027-02-12Earnings Report · ExpectedOn 2027-02-12, the 2026/Q4 earnings report is expected to be released.
Moderna (MRNA) Derivatives Trading
Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.
Contracts based on stock prices, with no expiration date. They support 24/7 long, short, and leveraged trading without holding the underlying shares. Be aware of funding fees and liquidation risk.
Moderna (MRNA) Company Financials
Valuation and Shares
- Market Cap
- $78.94B
- P/E Ratio (TTM)
- -27.69
- P/B Ratio
- 11.54
- Shares Outstanding
- 404.62M shares
- Float Shares
- 372.25M shares
- Dividend Yield (TTM)
- 0.00%
Latest Reported Financials
2026 Q3 FinancialsReport Release Date: 2026-11-06
Operating Revenue (Actual)
$1.31B
Same Period Last Year: +29.23%
Earnings per Share (Actual)
$0.38
Same Period Last Year: +174.51%
Financials · Actuals
| Actual Value | 2022/Annual | 2023/Annual | 2024/Annual | 2025/Annual |
|---|---|---|---|---|
| Revenue | $19.26B | $6.84B | $3.23B | $1.94B |
| Net Profit | $8.36B | -$4.71B | -$3.56B | -$2.82B |
| Operating Cash Flow | $4.98B | -$3.11B | -$3.00B | -$1.87B |
Learn
Blogs



MRNA FAQ
What is the current stock price of Moderna (MRNA)?
Which exchange is MRNA listed on?
How has Moderna stock performed over the past month?
What is the market cap of Moderna?
What are Moderna's latest financial results?
What factors may affect the stock price of Moderna (MRNA)?
Other Trading Markets
Risk Warning
Disclaimer







